Uwe Röhrhoff new Chief Executive Officer of Gerresheimer AG

DUSSELDORF, Germany, June 21, 2010 - Uwe Röhrhoff becomes the new Chief Executive Officer of
Gerresheimer AG on June 22, 2010. Uwe Röhrhoff, who has been a member of the
Management Board since 2003, was appointed to his new position by the
Supervisory Board in March. Uwe Röhrhoff (48) succeeds Dr. Axel Herberg, who
headed the business for ten years as CEO and is changing to the Supervisory
Board on September 1, 2010.

(Photo:
www.newscom.com/cgi-bin/prnh/20100621/396341 )

"We are delighted to have found in Uwe Röhrhoff the ideal CEO
for Gerresheimer AG," says Supervisory Board Chairman Gerhard Schulze: "Mr.
Röhrhoff stands for continuity and experience and enjoys the trust of
customers and employees equally."

Uwe Röhrhoff, a business graduate, works for Gerresheimer for
20 years and was recently responsible for the Moulded Glass Division and the
Life Science Research Division. In addition, he has played a decisive role in
the expansion of Gerresheimer's US and Chinese business. Uwe Röhrhoff
comments: "We will continue in the future to focus on the successful business
in the field of pharma and healthcare. At the same time we want to push ahead
with inter­nationalization. We are very well positioned and solidly financed
to achieve further profitable growth in the future."

As CEO, Uwe Röhrhoff will continue to manage the Moulded Glass
Divi­sion directly. On the Management Board, Dr. Max Raster takes over
responsibility for the Life Science Research Division in addition to the
Tubular Glass Division.

Uwe Röhrhoff joined Gerresheimer in 1991 and initially worked
in controlling. He became CEO of the US subsidiary Gerresheimer Glass Inc. in
2001 and has many years' experience of international busi­ness management.

Dr. Axel Herberg is leaving Gerresheimer under his own
volition after his successful work as CEO. Dr. Herberg served the company for
twenty years, fifteen of them as a member of the Management Board and ten as
CEO. The Supervisory Board thanks him for his outstanding achievements and
successful colla­bo­ration over the past years. It welcomes Dr. Axel Herberg
as a new member of the Supervisory Board, to which he was elected by the
Annual General Meeting on April 29, 2010 by a large majority of votes.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of
high-quality specialty products made of glass and plastic for the global
pharma & healthcare industry. Our wide product spectrum ranges from
pharma­ceutical vials to complex drug delivery systems, such as syringe
systems, insulin pens and inhalers, for safe dosage and appli­cation.
Together with our partners we develop solutions which set standards and have
role-model status throughout their respective business sectors.

Our Group of companies achieves in Europe, North and South
America and Asia sales of about EUR1 billion and employs around 9,400 people.
Through top-class technologies, convincing innovations and targeted
invest­ments we are systematically expanding our strong market position.

P.S.: If required, we can send you high-resolu­tion data.
Reprint free of charge. Please send specimen copy to Gerresheimer. (c)
Gerresheimer AG

    Press Contact Investor Relations Contact

    Jens Kürten
    Director Corporate Communication & Marketing
    Telephone: +49-211-6181-250
    Telefax:   +49-211-6181-241
    E-Mail j.kuerten@gerresheimer.com 

    Anke Linnartz
    Director Investor Relations
    Telephone: +49-211-6181-314
    Telefax:   +49-211-6181-121
    E-Mail: a.linnartz@gerresheimer.com

Photo:
www.newscom.com/cgi-bin/prnh/20100621/396341

Press Contact Investor Relations Contact: Jens Kurten, Director Corporate Communication & Marketing, Telephone: +49-211-6181-250, Telefax: +49-211-6181-241, E-Mail j.kuerten at gerresheimer.com; Anke Linnartz, Director Investor Relations, Telephone: +49-211-6181-314, Telefax: +49-211-6181-121, E-Mail a.linnartz at gerresheimer.com